drugset

drugset / Trial / NCT01023425

Clinical Trial of Donepezil Between the Naive Group and the Switching Group

NCT01023425 ↗

Completed 72 enrolled Samsung Medical Center Eisai Korea Inc. · collab

Non-randomizedParallel-groupOpen-labelTreatment

Summary

To compare the clinical efficacy of donepezil between the naive group and the switching group.

Timeline

Start: 2008-02
Primary completion: 2009-04
Completion: 2009-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Donepezil	Small molecule	10 mg	—

Indications